Dofetilide use is not associated with increased mortality in patients with left ventricular hypertrophy and atrial fibrillation-Reference-Cited by-同舟云学术

Dofetilide use is not associated with increased mortality in patients with left ventricular hypertrophy and atrial fibrillation

Published:2022-11-15 Issue:2 Volume:34 Page:447-452
ISSN:1045-3873
Container-title:Journal of Cardiovascular Electrophysiology
language:en
Short-container-title:Cardiovasc electrophysiol

Author:

Wann Daniel G.¹^ORCID,Medoff Brent S.¹,Mehdi Noor‐ul‐huda A.²,Sezer Ahmet¹,Thoma Floyd W.¹,Mulukutla Suresh¹,Bhonsale Aditya¹,Estes NA Mark¹^ORCID,Saba Samir¹^ORCID,Jain Sandeep K.¹^ORCID,

Affiliation:

1. Center for Atrial Fibrillation Heart and Vascular Institute, University of Pittsburgh Medical Center Pittsburgh Pennsylvania USA

2. Internal Medicine Medstar Washington Hospital Center District of Columbia Washington USA

Publisher

Wiley

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jce.15733

Reference19 articles.

1. Atrial fibrillation: Profile and burden of an evolving epidemic in the 21st century

2. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary

3. Association Between Diabetes Mellitus and Left Ventricular Hypertrophy in a Multiethnic Population

4. The Progression of Hypertensive Heart Disease

5. Meta-Analysis of Left Ventricular Hypertrophy and Sustained Arrhythmias

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heart rate and rhythm in cardiac amyloidosis;Trends in Cardiovascular Medicine;2023-03

2. Should we limit antiarrhythmic drug choice in patients with left ventricular hypertrophy?;Journal of Cardiovascular Electrophysiology;2022-11-09